Table of Contents

1 Report Prologue 11
2 Market Introduction 13
2.1 Introduction 13
2.2 Scope of the Study 13
2.2.1 Research Objective 13
2.2.2 Assumptions 13
2.2.3 Limitations 14
2.3 Market Structure 14
3 Research Methodology 15
3.1 Primary Research Methodology 16
3.2 Secondary Research Methodology 18
3.3 Market Share Analysis 19
3.4 Trade Analysis 19
3.5 Market Pricing Approach 19
4 Market Dynamics 20
4.1 Introduction 20
4.2 Drivers 21
4.2.1 Increasing demand for dry powder inhalers (DPI) products (Impact Weightage: 30%) 21
4.2.2 Compatibility with active ingredients and other excipients (Impact Weightage: 15%) 22
4.2.3 Approval from government bodies (Impact Weightage: 25%) 23
4.2.4 Drug formulation coupled with nanotechnology will boost the growth of pharmaceutical grade lactose market (Impact Weightage: 30%) 24
4.3 Restrains 25
4.3.1 Lactose-induced problems (Impact Weightage: 40%) 25
4.3.2 Stringent government regulations (Impact Weightage: 30%)\ 26
4.3.3 Lack compatibility with amine based drugs (Impact Weightage: 30%) 27
4.4 Opportunity 28
4.5 Mega Trends 28
4.5.1 Using lactose as excipient in nanotechnology-based drug formulations 28
4.6 Macroeconomic Indicators 28
4.7 Technology Trends & Assessment 29
5 Market Factor Analysis 30
5.1 Value Chain Analysis 30
5.1.1 R&D 30
5.1.2 Manufacturing 30
5.1.3 Distribution & Sales 31
5.1.4 Post-sales Monitoring 31
5.2 Porters Five Forces Model 32
5.2.1 Bargaining power of suppliers (Medium to High) 33
5.2.2 Bargaining Power of Buyers (low to medium) 33
5.2.3 Threat of New Entrants (low to medium) 33
5.2.4 Threat of Substitutes (High) 33
5.2.5 Intensity of Rivalry (Medium) 33
5.3 Demand & Supply: Gap Analysis 34
5.3.1 Pricing Analysis 34
5.3.2 Investment Opportunity Analysis 34
6 Pharmaceutical Grade Lactose Market, by Type 35
6.1 Introduction 35
6.2 Crystalline Monohydrate Lactose 38
6.3 Inhalation Lactose 39
6.4 Granulated Lactose 40
6.5 Spray Dried Lactose 41
7 Global Pharmaceutical Grade Lactose Market, by Application 42
7.1 Introduction 42
7.2 Tablets Manufacturing 44
7.3 Capsule Manufacturing 45
8 Global Pharmaceutical Grade Lactose Market, by Region 46
8.1 Introduction 46
8.2 Europe 48
8.2.1 Western Europe 52
8.2.1.1 Germany 54
8.2.1.2 France 56
8.2.1.3 UK 58
8.2.1.4 Italy 60
8.2.1.5 Spain 62
8.2.1.6 Rest of Western Europe 64
8.2.2 Eastern Europe 66
8.3 Asia Pacific 68
8.3.1 Japan 72
8.3.2 China 74
8.3.3 India 76
8.3.4 Republic of Korea 78
8.3.5 Australia 80
8.3.6 Rest of Asia Pacific 82
?
8.4 Americas 84
8.4.1 North America 87
8.4.1.1 U.S. 89
8.4.1.2 Canada 91
8.4.2 South America 93
8.5 Middle East & Africa 95
8.5.1 Middle East 98
8.5.2 Africa 100
9 Company Landscape 102
9.1 Company Share Analysis 102
9.2 Competitive Landscape 103
10 Company Profiles 104
10.1 BASF SE 104
10.1.1 Company Overview 104
10.1.2 Financials 104
10.1.3 Products 104
10.1.4 Strategy 104
10.1.5 Key Developments 104
10.2 Merck KGaA 105
10.2.1 Company Overview 105
10.2.2 Financials 105
10.2.3 Products 105
10.2.4 Strategy 105
10.2.5 Key Developments 105
10.3 Kerry Inc. 106
10.3.1 Company Overview 106
10.3.2 Financials 106
10.3.3 Products 106
10.3.4 Strategy 106
10.3.5 Key Developments 106
10.4 DFE Pharma 107
10.4.1 Company Overview 107
10.4.2 Financials 107
10.4.3 Products 107
10.4.4 Strategy 107
10.4.5 Key Developments 107
10.5 Meggle 108
10.5.1 Company Overview 108
10.5.2 Financials 108
10.5.3 Products 108
10.5.4 Strategy 108
10.5.5 Key Developments 108
10.6 Armor Pharma 109
10.6.1 Company Overview 109
10.6.2 Financials 109
10.6.3 Products 109
10.6.4 Strategy 109
10.6.5 Key Developments 109
10.7 ALPAVIT 110
10.7.1 Company Overview 110
10.7.2 Financials 110
10.7.3 Products 110
10.7.4 Strategy 110
10.7.5 Key Developments 110
11 MRFR Conclusion 111
11.1 Key Findings 111
11.1.1 From CEO's view point 111
11.2 Key Companies to Watch 111
12 Appendix 112
12.1 Discussion Blue Print 112